The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials. The fund’s portfolio managers apply rigorous fundamental credit research to identify bonds offering attractive risk-return characteristics. In addition to high-yield bonds, the fund may invest in bank loans, floating-rate obligations, and other income-generating instruments to broaden its exposure and manage interest-rate risk.
Advised by Neuberger Berman Investment Advisers, LLC, the fund benefits from the firm’s global credit research platform and robust risk-management capabilities. Neuberger Berman’s investment team, headquartered in New York, combines top-down macroeconomic analysis with bottom-up issuer research to construct the fund’s portfolio. To enhance income potential, NHS may employ leverage through borrowing and preferred share issuance, in accordance with the limits set forth in its prospectus.
NHS distributes income on a monthly basis, offering a consistent cash flow stream for shareholders seeking yield in a low-rate environment. Listed on the NYSE American exchange, the fund serves both individual and institutional investors by providing convenient access to the high-yield market under professional management and with a broadly diversified portfolio.
AI Generated. May Contain Errors.
